EQ

Equillium

• TipRanks·10/27 13:36

  Equillium (EQ) Receives a Rating Update from a Top Analyst

• TipRanks·10/26 22:45

  Roth Capital says buy Equillium ahead of EQ504 readout

• TipRanks·10/26 21:28

  Equillium advances EQ504 trial and extends cash runway

• TipRanks·10/26 13:20

  Equillium doses first subject in Phase 1 trial of EQ504

• Dow Jones·10/12 12:39

  Equillium Coverage Assumed by Leerink Partners at Outperform

• Dow Jones·10/12 12:39

  Equillium Price Target Announced at $6.00/Share by Leerink Partners

• TipRanks·10/12 11:36

  Equillium (EQ) Receives a Rating Update from a Top Analyst

• TipRanks·10/12 11:15

  Equillium assumed with an Outperform at Leerink

• TipRanks·10/09 16:31

  Equillium’s EQ504 Steps Into the Clinic: What Early Trial Plans Mean for Investors

• NASDAQ·10/07 10:52

  Equillium Gains Australian Nod For Phase 1 Study Of EQ504; Dosing In Nov'26

• TipRanks·10/06 11:20

  Analysts’ Top Healthcare Picks: Equillium (EQ), NeoGenomics (NEO)

• TipRanks·10/06 06:55

  Roth MKM Sticks to Its Buy Rating for Equillium (EQ)

• TipRanks·10/05 21:57

  Equillium Advances EQ504 With Phase 1 Trial Clearance

• TipRanks·10/05 20:15

  Equillium receives HREC clearance for EQ504 in Australia

• NASDAQ·10/02 18:40

  Friday Sector Laggards: Information Technology Services, Drugs